Create a narrative

Haemonetics Community

NYSE:HAE Community

3 Narratives written by author
0 Comments on narratives written by author
8 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 10 Analysts

Shift To High-Margin Interventional Technologies Will Strengthen Future Prospects

Key Takeaways Strategic divestitures and focus on high-margin segments expected to enhance profitability and drive revenue and margin growth. New agreements and innovations in Blood Management Technologies position Haemonetics for significant market share increases and global technology adoption.

US$96.30

FV

29.4% undervalued

5.07%

Revenue growth p.a.

0

0

5

1 day ago